CN106282313B - 一种用于低密度脂蛋白胆固醇测定试剂的稳定剂 - Google Patents

一种用于低密度脂蛋白胆固醇测定试剂的稳定剂 Download PDF

Info

Publication number
CN106282313B
CN106282313B CN201610692013.9A CN201610692013A CN106282313B CN 106282313 B CN106282313 B CN 106282313B CN 201610692013 A CN201610692013 A CN 201610692013A CN 106282313 B CN106282313 B CN 106282313B
Authority
CN
China
Prior art keywords
reagent
density lipoprotein
low
stabilizer
lipoprotein cholesterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610692013.9A
Other languages
English (en)
Other versions
CN106282313A (zh
Inventor
王新刚
蔡润中
付勇
苟晓刚
宫在科
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Weihai Wishtech Medical Technology Co ltd
Original Assignee
Weihai Wishtech Medical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Weihai Wishtech Medical Technology Co ltd filed Critical Weihai Wishtech Medical Technology Co ltd
Priority to CN201610692013.9A priority Critical patent/CN106282313B/zh
Publication of CN106282313A publication Critical patent/CN106282313A/zh
Application granted granted Critical
Publication of CN106282313B publication Critical patent/CN106282313B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/60Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/30Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving catalase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2326/00Chromogens for determinations of oxidoreductase enzymes
    • C12Q2326/90Developer
    • C12Q2326/964-Amino-antipyrine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

本发明涉及体外诊断试剂技术领域,具体地说是一种用于低密度脂蛋白胆固醇测定试剂的稳定剂,其特征在于该稳定剂由明胶、MgSO4、甘油、甜菜碱、海藻糖、聚乙二醇、EDTA组成,用于低密度脂蛋白胆固醇测定试剂的稳定剂,可以显著延长低密度脂蛋白胆固醇测定试剂的有效期至2年,开瓶稳定性达到3个月,且明显降低空白吸光度值,试剂操作简单,结果准确,稳定性好。

Description

一种用于低密度脂蛋白胆固醇测定试剂的稳定剂
技术领域
本发明涉及体外诊断试剂技术领域,具体地说是一种配置简单、试剂有效期增长、开瓶稳定性高的用于低密度脂蛋白胆固醇测定试剂的稳定剂。
背景技术
众所周知,低密度脂蛋白胆固醇用于冠心病和动脉粥样硬化的诊断。动脉粥样硬化(AS)斑块中沉淀的脂质主要是低密度脂蛋白(LDL),在各类脂质中,LDL被认为是主要的致病因素,而高密度脂蛋白(HDL)可能起保护作用,血清总胆固醇(TC)大,致反映LDL胆固醇(LDL-CHO)水平,但也受HDL-C水平的影响,因此在AS脂类危险因素判别中,TC偏高时,测定LDL-C有重要临床意义。
目前,低密度脂蛋白胆固醇检测试剂盒多采用直接法-表面活性剂清除法,由于其高灵敏度,高准确性、高精密性及适用性而在临床上广泛使用,但因为酶的活性会受到PH、温度、化学试剂的干扰,从而导致检测试剂存在稳定性差的问题,影响临床使用,目前市场上的低密度脂蛋白胆固醇检测试剂的保存条件及期限为,未开封试剂避光保存于2~8℃,有效期12个月;试剂开封后避光保存于2~8℃,在无污染情况下有效期1个月。
发明内容
本发明的目的是解决上述现有技术的不足,提供一种配置简单、试剂有效期增长、开瓶稳定性高的用于低密度脂蛋白胆固醇测定试剂的稳定剂。
本发明解决其技术问题所采用的技术方案是:
一种用于低密度脂蛋白胆固醇测定试剂的稳定剂,其特征在于该稳定剂由明胶 、MgSO4 、甘油 、甜菜碱、海藻糖 、聚乙二醇、EDTA 组成,其重量组分为:明胶 1~10ml/L,MgSO4 0.1~5g/L,甘油 1~15ml/L,甜菜碱0.1~1mol/L,海藻糖 0.1g/L~20 g/L,聚乙二醇 0.5~2g/L,EDTA 0.5~2.0g/L。
本发明中用于低密度脂蛋白胆固醇检测试剂,由试剂1和试剂2组成:
R1:PIPES-Na 80mmol/L,胆固醇酯酶 2KU/L,胆固醇氧化酶 2KU/L,过氧化氢酶200LU/L,4-氨基安替比林 200mmol/L,三甲基-β-环糊精 5g/L,环氧乙烷十八烷胺 3g/L,亚铁氰化钾 50μmol/L,氯化钠 25ml/L,Proclin300 0.05%。
R2: PIPES-Na 80mmol/L,过氧化物酶 2KU/L,氯化钠 0.9g/L,BSA 1.5g/L,叠氮钠 2.0g/L,TritonX-100 18g/L。
本发明所述稳定剂的使用量在试剂中的体积为5 ml/L。
本发明所述的稳定剂的PH为6.8-7.0,PH对于酶的活性有很大的影响,影响机制很复杂,主要有下列几个方面:1.pH过小(过酸)、过大(过碱)都能使酶蛋白变性而失活.2.pH的改变能影响酶活性中心上必须基团的解离程度,同时也可以影响底物和辅酶的解离程度,从而影响酶分子对底物分子的结合和催化,只有在特定的pH下,酶、底物和辅酶的解离状态,最适宜它们相互结合,并发生催化作用,从而使酶反应速度达到最大值。这个pH称为酶的最适PH(optimun pH)酶的最适pH不是一个常数,它的大小与底物的种类和浓度、缓冲液的性质和浓度、介质的离子浓度、温度、反应时间有关,在测定某种酶的活力时,采用该酶的最适pH,并用适当的缓冲液维持最适pH。
本发明由于该稳定剂由明胶 、MgSO4 、甘油 、甜菜碱、海藻糖 、聚乙二醇、EDTA组成,用于低密度脂蛋白胆固醇测定试剂的稳定剂,可以显著延长低密度脂蛋白胆固醇测定试剂的有效期至2年,开瓶稳定性达到3个月,且明显降低空白吸光度值,试剂操作简单,结果准确,稳定性好。
具体实施方式
一种用于低密度脂蛋白胆固醇测定试剂的稳定剂,其特征在于该稳定剂由明胶 、MgSO4 、甘油 、甜菜碱、海藻糖 、聚乙二醇、EDTA 组成,其重量组分为:明胶 1~10ml/L,MgSO4 0.1~5g/L,甘油 1~15ml/L,甜菜碱0.1~1mol/L,海藻糖 0.1g/L~20 g/L,聚乙二醇 0.5~2g/L,EDTA 0.5~2.0g/L,所述的用于低密度脂蛋白胆固醇检测试剂,由试剂1和试剂2组成:R1:PIPES-Na 80mmol/L,胆固醇酯酶 2KU/L,胆固醇氧化酶 2KU/L,过氧化氢酶200LU/L,4-氨基安替比林 200mmol/L,三甲基-β-环糊精 5g/L,环氧乙烷十八烷胺 3g/L,亚铁氰化钾 50μmol/L,氯化钠 25ml/L,Proclin300 0.05%,R2: PIPES-Na 80mmol/L,过氧化物酶 2KU/L,氯化钠 0.9g/L,BSA 1.5g/L,叠氮钠 2.0g/L,TritonX-100 18g/L,所述稳定剂的使用量在试剂中的体积为5 ml/L,所述的试剂的PH为6.8-7.0,这个PH值是胆固醇酯酶,胆固醇氧化酶及过氧化氢酶的最适PH值,在此PH值的条件下,可以有效的保护酶不发生变性而失活,以延长酶的活性,从而有效的延长试剂的稳定性。在此PH值范围内,加入样品后,酶可以最大程度的催化反应,从而使酶反应速度达到最大值。
低密度脂蛋白胆固醇检测试剂的反应原理为:
(1)具有特异选择性的缓冲液作用于血清中CM、VLDL、HDL,并在胆固醇酯酶和胆固醇氧化酶的催化下反应生成H2O2,H2O2被过氧化氢酶分解为H2O和O2,此时由于缺少Trinder反应的其中一个色原,测定体系不显色;
(2)在表面活性剂的作用下,胆固醇酯酶和胆固醇氧化酶催化LDL-C反应并显色,用生化分析仪比色定量。
反应一:CM VLDL HDL + 选择性抑制剂 + CHER + CHOD→ 4-胆甾烯酮 + H2O2
H2O2 + CAT→H2O + O2
反应二:LDL+叠氮钠+表面活性剂+ CHER+CHOD→ 4-胆甾烯酮+H2O2
H2O2 + 4-AAP +HRP→苯醌亚胺色素
本发明高/低密度脂蛋白胆固醇检测试剂,适用于各类自动、半自动生化仪,以奥林巴斯AU400全自动生化仪为例,其操作如下:
Figure 741482DEST_PATH_IMAGE002
分析方法:终点法,试剂的用量为R1 225ul,样本量为3ul,将样本加入试剂1于37℃孵育3~5分钟后读取吸光度值A1,然后加入试剂2,加样量为75 ul,于37℃孵育5分钟后读取吸光度值A2,检测波长主波长为546nm,副波长为700nm。
本实验的目的是检测试剂的空白吸光度值、开瓶稳定性、长效稳定性。
操作步骤:使用定标液定标,取三个水平的质控各测定10次,取平均值,计算相对偏差。质控采用朗道质控(CAT.NO.LE2663 LOT.NO.2162CH LOT.NO.2220CHLOT.NO.2141CH),三个水平的靶值范围分别为
Figure 658622DEST_PATH_IMAGE004
结果分析:根据检测数据,计算测定值均值、相对偏差。
表一结果显示,本发明试剂空白本地明显低于对比试剂,表明试剂的准确度高,精密性好,测试误差小,干扰因素少。
表二结果显示,对比试剂仅在一个月内表现出良好的测试结果,后期偏离靶值幅度较大,而本发明试剂在开瓶后3个月,对同一质控测定10次,相对偏差均小于6%,表明试剂在开瓶后非常稳定,准确性良好,为测试人员提供了方便快捷的检测试剂。
表三结果显示,对比试剂仅在一年内内表现出良好的测试结果,后期偏离靶值幅度较大,而本发明试剂在规定的储存条件下放置两年后,试剂依然非常稳定,相对偏差均小于6%,准确性好。显著延长了试剂的使用期限。
表1:低密度脂蛋白胆固醇检测试剂盒
空白吸光度值 不加稳定剂 加入稳定剂
OD(均值) 0.1513 0.0481
表2:低密度脂蛋白胆固醇检测试剂盒
Figure 500676DEST_PATH_IMAGE006
表3:低密度脂蛋白胆固醇检测试剂盒
Figure 82836DEST_PATH_IMAGE008
本发明试剂中一定比例的MgSO4及过氧化氢酶起到了降低空白本底的作用,其中过氧化氢酶通过催化过氧化氢反应生成水和氧气从而减少因4-氨基安替比林被氧化而产生的颜色反应,达到降低空白本底的效果。 MgSO4的硫酸根离子可以降低4-氨基安替比林被氧化的速度而减少因4-氨基安替比林被氧化而产生的颜色反应,从而降低空白本底。
含有MgSO4及过氧化氢酶与不含有MgSO4及过氧化氢酶的对比试验实验数据:
Figure 834892DEST_PATH_IMAGE010
本发明试剂中一定比例的明胶可以减缓有机试剂对酶的失活作用。甘油及甜菜碱起到抑制酶分子间聚集的作用,维持酶分子的二级结构,增强酶的稳定性。海藻糖即可通过氢键与酶表面分子结合,稳定酶活性,也可抑制酶分子间聚集,有效阻止酶分子变性失活。聚乙二醇具有疏水亲水的双重特性,可以提高酶的稳定性。酶分子易受到蛋白水解酶的影响,一旦条件适宜,就会发生水解反应,EDTA可避免水解现象,维持酶分子的活性。
Figure 867742DEST_PATH_IMAGE012
Figure 72459DEST_PATH_IMAGE014
本发明的用于低密度脂蛋白胆固醇测定试剂的稳定剂,可以显著延长高/低密度脂蛋白胆固醇测定试剂的有效期至2年,开瓶稳定性达到3个月,且明显降低空白吸光度值,试剂操作简单,结果准确,稳定性好,实验采用奥林巴斯AU400全自动生化仪进行,但本发明的试剂不限于上述仪器,还适用于其他半自动或全自动生化分析仪。
现有的低密度脂蛋白胆固醇检测试剂的成分有胆固醇酯酶、胆固醇氧化酶、过氧化物酶、tween-80、曲拉通x-100、4-氨基安替比林、缓冲液,没有稳定剂,所以开瓶稳定性仅一个月,开瓶效期仅一年。

Claims (3)

1.一种用于低密度脂蛋白胆固醇测定试剂的稳定剂,其特征在于该稳定剂由明胶 、MgSO4 、甘油 、甜菜碱、海藻糖 、聚乙二醇、EDTA 组成,其重量组分为:明胶 1~10ml/L,MgSO4 0.1~5g/L,甘油 1~15ml/L,甜菜碱0.1~1mol/L,海藻糖 0.1g/L~20 g/L,聚乙二醇 0.5~2g/L,EDTA 0.5~2.0g/L,所述的用于低密度脂蛋白胆固醇检测试剂,由试剂1和试剂2组成:
R1:PIPES-Na 80mmol/L,胆固醇酯酶 2KU/L,胆固醇氧化酶 2KU/L,过氧化氢酶200LU/L,4-氨基安替比林 200mmol/L,三甲基-β-环糊精 5g/L,环氧乙烷十八烷胺 3g/L,亚铁氰化钾 50μmol/L,氯化钠 25ml/L,Proclin300 0.05%;
R2: PIPES-Na 80mmol/L,过氧化物酶 2KU/L,氯化钠 0.9g/L,BSA 1.5g/L,叠氮钠2.0g/L,TritonX-100 18g/L。
2.根据权利要求1所述的一种用于低密度脂蛋白胆固醇测定试剂的稳定剂,其特征在于所述的稳定剂的使用量在试剂中的体积为5 ml/L。
3.根据权利要求1所述的一种用于低密度脂蛋白胆固醇测定试剂的稳定剂,其特征在于所述的稳定剂的PH为6.8-7.0。
CN201610692013.9A 2016-08-19 2016-08-19 一种用于低密度脂蛋白胆固醇测定试剂的稳定剂 Active CN106282313B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610692013.9A CN106282313B (zh) 2016-08-19 2016-08-19 一种用于低密度脂蛋白胆固醇测定试剂的稳定剂

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610692013.9A CN106282313B (zh) 2016-08-19 2016-08-19 一种用于低密度脂蛋白胆固醇测定试剂的稳定剂

Publications (2)

Publication Number Publication Date
CN106282313A CN106282313A (zh) 2017-01-04
CN106282313B true CN106282313B (zh) 2020-05-26

Family

ID=57661513

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610692013.9A Active CN106282313B (zh) 2016-08-19 2016-08-19 一种用于低密度脂蛋白胆固醇测定试剂的稳定剂

Country Status (1)

Country Link
CN (1) CN106282313B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108690869A (zh) * 2017-04-05 2018-10-23 广州市伊川生物科技有限公司 一种高密度脂蛋白胆固醇检测试剂盒及其检测方法
CN108949903B (zh) * 2017-05-17 2021-11-16 广州市伊川生物科技有限公司 一种甘油三酯测定试剂盒及其测定方法
CN108424952B (zh) * 2018-03-21 2021-04-20 天津中成佳益生物科技有限公司 一种小而密低密度脂蛋白胆固醇检测试剂盒
CN113308513B (zh) * 2021-05-27 2022-02-18 宁波瑞源生物科技有限公司 一种小而密低密度脂蛋白胆固醇检测试剂盒及其检测方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1379234A (zh) * 2002-05-10 2002-11-13 肖洪武 低密度脂蛋白胆固醇测定方法及试剂
CN1446925A (zh) * 2003-03-24 2003-10-08 肖洪武 稳定的单一液态酶比色试剂及其应用
CN102041296A (zh) * 2009-10-09 2011-05-04 温州医学院 一种血清低密度脂蛋白胆固醇(ldl-c)匀相法体外诊断试剂
CN105652021A (zh) * 2016-03-11 2016-06-08 上海练佰生物技术中心 一种测定小而密脂蛋白的试剂、方法和试剂盒

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1379234A (zh) * 2002-05-10 2002-11-13 肖洪武 低密度脂蛋白胆固醇测定方法及试剂
CN1446925A (zh) * 2003-03-24 2003-10-08 肖洪武 稳定的单一液态酶比色试剂及其应用
CN102041296A (zh) * 2009-10-09 2011-05-04 温州医学院 一种血清低密度脂蛋白胆固醇(ldl-c)匀相法体外诊断试剂
CN105652021A (zh) * 2016-03-11 2016-06-08 上海练佰生物技术中心 一种测定小而密脂蛋白的试剂、方法和试剂盒

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
胆固醇氧化酶亲和纯化及酶稳定剂研究;陈亦;《中国优秀硕士学位论文全文数据库 基础科学辑》;20131215(第S1期);第25-27、29-31页 *

Also Published As

Publication number Publication date
CN106282313A (zh) 2017-01-04

Similar Documents

Publication Publication Date Title
CN102721684B (zh) 血清中肌酐的二步酶法测定方法及测定试剂
CN106282313B (zh) 一种用于低密度脂蛋白胆固醇测定试剂的稳定剂
CN106191211B (zh) 一种用于高密度脂蛋白胆固醇检测试剂的稳定剂
JPH0577399B2 (zh)
US3977944A (en) Enzyme-kinetic determination of the concentration of a substrate
CS228127B2 (en) Reagencni cinidlo
Sampson et al. Chemical inhibition used in a kinetic urease/glutamate dehydrogenase method for urea in serum.
CN111944872A (zh) 测定肌酐含量的试剂组合、试剂或试剂盒
CN107505470A (zh) 稳定的肌酐检测试剂盒及其使用方法
CN109813918B (zh) 一种总胆红素测定试剂盒
CN114381494B (zh) 一种乳酸脱氢酶同工酶1的检测试剂及检测方法
CN106086158A (zh) 一种测定α‑羟丁酸脱氢酶的试剂盒及其制备方法
CN109541238A (zh) 直接胆红素测定方法及试剂盒
CN102262066A (zh) 一种检测单胺氧化酶含量的方法和试剂盒
CN106244672A (zh) 一种用于尿酸检测试剂的稳定剂
CN111154833B (zh) 一种α-L-岩藻糖苷酶测定试剂盒
WO2005029038A2 (en) Detection of potassium ions using ion-sensitive enzymes
CS227331B2 (en) Method of glycerol determination
CN111057746A (zh) 一种肌酸激酶同工酶测定试剂盒
Cheng et al. Rapid assay of galactose in blood serum and urine by amperometric measurement of enzyme-catalyzed oxygen consumption
CN110082306A (zh) 单胺氧化酶测定试剂盒
CN108918435A (zh) 胆红素测定方法及试剂盒
JP4081709B2 (ja) 夾雑物質による影響回避方法
JPS61173799A (ja) 基質又は酵素活性の定量方法
Waldstein et al. Determination of Exogenous Galactose in Blood using" Specially Purified" Glucose Oxidase

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A Stabilizer for Low Density Lipoprotein Cholesterol Determination Reagent

Effective date of registration: 20220923

Granted publication date: 20200526

Pledgee: Weihai City Commercial Bank Co.,Ltd. Park sub branch

Pledgor: WEIHAI WISHTECH MEDICAL TECHNOLOGY CO.,LTD.

Registration number: Y2022980016001

PE01 Entry into force of the registration of the contract for pledge of patent right